Andrew Behrens
Analyst
Leerink
Equibles does not estimate personal net worth.
About Andrew Behrens
Andrew Behrens is recorded as Analyst at Leerink. Andrew Behrens has spoken on 1 earnings call and 3 other investor events across 2 companies, most recently for Tango Therapeutics, Inc. on October 23, 2026. Those appearances were for Agios Pharmaceuticals, Inc. (AGIO) and Tango Therapeutics, Inc. (TNGX). The companies whose calls Andrew Behrens spoke on are classified in the Healthcare sector.
Andrew Behrens on recent calls
“Adam, can you give a little more color on the scientific rationale for using our PRMT5 agent in the MTAP wild-type setting? And would you expect the results to be as dramatic in these patients without a loss of function?”
“I guess I just want to expand a little bit on the persistence, right, since it's so important going forward. Is there anything that you can tell us about maybe the expanded access program at all?”
“I guess I just want to expand a little bit on the persistence, right, since it's so important going forward. Is there anything that you can tell us about maybe the expanded access program at all?”
“Hi, thanks, and congrats, Brian, and team, on the progress and the plenary session at the meeting. I guess a question on the label.”
Affiliation history
-
Leerink
Analyst
Transcript header (unverified)
Current